<DOC>
<DOCNO>EP-0626968</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PIPERIDINYL THIACYCLIC DERIVATIVES
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K314433	A61K314523	A61K31454	A61P3700	A61P3708	C07D40906	C07D41706	A61K31445	C07D41714	C07D41700	C07D40914	C07D40900	A61K31445	A61K314427	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61P	A61P	C07D	C07D	A61K	C07D	C07D	C07D	C07D	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61P37	A61P37	C07D409	C07D417	A61K31	C07D417	C07D417	C07D409	C07D409	A61K31	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Piperidinyl thiacyclic derivatives useful in the treatment of allergic diseases and diseases responding to antagonism of 5HT2 receptors, pharmaceutical compositions and methods of treatment using these compounds.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
The present invention is directed to compounds and
pharmaceutical compositions thereof.The compounds of the present invention are
piperidinyl thiacyclic derivatives useful in the treatment
of allergic diseases and the treatment of diseases
responsive to serotonin 5HT2 antagonists.In EP-A-0 013 612 (piperidinylalkyl) quinazoline derivatives
and intermediates are disclosed, including intermediates of
formula I below, wherein R2 and R3 are hydrogen, X is -CH or
-carbon and R1 is benzyl or COR8 wherein R8 is C1-C4-alkoxy.US-A 283 405 discloses piperidinyl derivatives wherein the
cyclic N-atom may bear a C3-C8 cycloalkyl group or a C1-C20
alkyl group containing up to two hydroxy groups. These
compounds are described as having antiischaemic and
hypertensive properties.In Chem. Abs. vol. 92 (1980) Abs. No. 198261b the compounds
4-(Dithien-2-yl-methylene/and methoxy)-1-methylpiperidine
are disclosed.JP-A 6 452 776 discloses benzothiazolinone derivatives
useful as antiallergic or antiinflammatory agents.J. Med. Chem. (30), 1987, 1-12 discusses central serotonin
receptors as targets for drug research.US-A 4 810 213 discloses arylalkyl-heterocyclic amines, N-substituted
by aryloxyalkyl groups and their use in the
treatment of allergy.The present invention comprises compounds of Formula I:

optical isomers or pharmaceutically acceptable salts
thereof,
wherein
Yis -C(=O)-, -C(=CH2)-, -C(H)(OH)-,  
-C(OH)(phenyl)- or -C(B)(OH) wherein B is

andYis attached at the heterocycle positions 2 or 3, or Y
is also attached at 2' or 3' when B is present.X and X'are the same or different and are carbon, CH or
nitrogen, provided that when Y is attached at the 3 or
3' position, X and X' are each carbon, and when Y is
attached at the 2 or 2' position, X and X' are the same
or different and are CH or nitrogen;R1is -(CH2)n-Z-(CH2)mCOR5, -C(O)R8 or
R2, R3, R2' and R3'are the same or different and are
hydrogen or C1-4 alkyl, or when R2 and R3, and R2' and
R3' are respectively taken together, with the atoms to
which R2 and R3, and R2' and R3' are respectively
attached, each form a phenyl moiety respectively
substituted with R4 or R4';Zis a bond, O, or S;R4 or R4'are the same or different and are hydrogen,
chloro, fluoro, C1-4 alkyl, or C1-4 alkoxy;R5is OH, C1-4 alkoxy or -NR6R7;R6 and R7are the same or different and are H or C1-4
alkyl;R8is C1-4 alkyl or C1-4 alkoxy; R9is H, C1-4 alkyl, C1-4 alkoxy, OH, chloro, bromo,
fluoro, -CF3, -NHC(O)R10, or CO2R11;R10is C1-4 alkyl or C1-4 alkoxy;R11is hydrogen or C1-4 alkyl;nis an integer from
</DESCRIPTION>
<CLAIMS>
A compound of the formula:


optical isomers or pharmaceutically acceptable salts
thereof,

wherein

Y
is -C(=O)-, -C(=CH
2
)-, -C(H)(OH)-, -C(OH)(phenyl)-
or -C(B)(OH) wherein B is



and
Y
is attached at the heterocycle position 2 or 3, and
when Y is -C(B)(OH), B is attached at heterocycle

positions 2' or 3';
X and X'
are the same or different and are carbon, CH
or nitrogen, provided that when Y is attached at

the 3 or 3' position X and X' are each carbon, and
when Y is attached at the 2 or 2' position X and

X' are the same or different and are CH or
nitrogen;
R
1
is -(CH
2
)
n
-Z-(CH
2
)
m
COR
5
, -C(O)R
8
 or 

R
2
, R
3
, R
2
' and R
3
'
are the same or different and are
hydrogen or C
1-4
 alkyl, or when R
2
 and R
3
, and R
2
'
and R
3
' are respectively taken together, with the
atoms to which R
2
 and R
3
, and R
2
' and R
3
' are
respectively attached, each form a phenyl moiety

respectively substituted with R
4
 or R
4
';
Z
is a bond, O, or S;
R
4
 or R
4
'
are the same or different and are hydrogen,
chloro, fluoro, C
1-4
 alkyl, or C
1-4
 alkoxy;
R
5
is OH, C
1-4
 alkoxy or -NR
6
R
7
;
R
6
 and R
7
are the same or different and are H or C
1-4

alkyl;
R
8
is C
1-4
 alkyl, C
1-4
 alkoxy;
R
9
is H, C
1-4
 alkyl, C
1-4
 alkoxy, OH, chloro, bromo,
fluoro, -CF
3
, -NHC(O)R
10
, or CO
2
R
11
;
R
10
is C
1-4
 alkyl or C
1-4
 alkoxy;
R
11
is hydrogen or C
1-4
 alkyl;
n
is an integer from 0-3 provided that when Z is not
a bond, n is an integer from 2-3;
m
is an integer from 1 to 3;
d
is an integer from 1-5; and
e
is zero or 1, provided that when e is 1:

d
is an integer from 2 to 5; and
X
is N or R
2
 and R
3
, with the atoms to which R
2

and R
3
 are attached, form a phenyl moiety; and
further provided that when R
2
 and R
3

are hydrogen, Y is CO or CHOH and X
is CH, R
1
 is not benzyl or COR
8

wherein R
8
 is C
1
-C
4
 alkoxy.
The compound of claim 1 wherein R
2
 and R
3
 together,
with the atoms to which R
2
 and R
3
 are attached, form a
phenyl moiety.
The compound of claim 1 wherein X is nitrogen.
The compound of claim 1 wherein R
1
 is

The compound of claim 4 wherein d is 2, e is 0 and
R
9
 is CO
2
R
11
.
The compound of claim 1 wherein R
2
 and R
3
 together,
with the atoms to which R
2
 and R
3
 are attached, form a
phenyl moiety and X is nitrogen.
The compound of claim 1 wherein R
2
 and R
3
 together,
with the atoms to which R
2
 and R
3
 are attached, form a
phenyl moiety and X is CH or carbon.
The compound of claim 1 wherein X is CH or carbon.
The compound of claim 1 wherein Y is -C(=O)-.
The compound of claim 1 wherein Y is -C(H)(OH)-.
The compound of claim 1 which is [2-Benzothiazolyl][1-[2-(4-methoxyphenyl)ethyl]
-4-piperidinyl]methanone

or any pharmaceutically acceptable
addition salt thereof. 
A pharmaceutical composition comprising the
compound of claim 1 including compounds wherein R
2
 and R
3
 are hydrogen, Y is CO or CHOH, X is CH and R
1
 is benzyl or COR
8
 wherein R
8
 is C
1
-C
4
 alkoxy.
Use of a compound as defined in claim 12
in the preparation of a medicine for the treatment of

allergic disease.
Use of a compound as defined in claim 12
in the preparation of a medicine for treating a disease

responsive to antagonism of the 5HT
2
 receptor.
Use of a compound according to any of claims 1-11
for the preparation of a medicine.
A method preparing a compound of formula (I) as defined in claim 1 comprising:

a) deprotecting a compound of formula (3)


to make a compound of Formula (4): 


as previously defined;
(b) optionally reacting compound (4) with R
1
'-Hal in
the presence of an appropriate base to form

compound (6):

 
as previously defined and wherein Hal is Cl, Br or I;
(c) optionally reducing the carbonyl functionality of
compound (4) with a reducing agent to produce

compound (7):


as previously defined;
(d) optionally converting the carbonyl functionality of
compound (4) to an ethenylene group by reacting

compound (7) with a suitable ylid to produce
compound (8):



as previously defined;
(e) optionally converting the carbonyl functionality of
compound (6) to a phenyl tertiary alcohol or

thiacyclic tertiary alcohol by reacting
phenyllithium or



to produce compound (9):

as previously defined, and wherein Y' is phenyl or 


as previously defined; or
(f) optionally preparing pharmaceutically acceptable
addition salts of Formula I.
</CLAIMS>
</TEXT>
</DOC>
